Company research
FOXO TECHNOLOGIES INC.
CIK 1812360Updated Sep 24, 2026
SecuritiesFOXO · OTC · equityFOXOW · OTC · warrant
Name history
Delwinds Insurance Acquisition Corp. · through Sep 15, 2022
FOXO price & chart
Loading TradingView…
OTC:FOXO on TradingView ↗About the company
We are a healthcare services and technology company operating in three reportable business segments: (i) Healthcare, (ii) Life Science Services and (iii) Labs, formerly referred to as Labs and Life. These segments further operate in four synergistic divisions, a rural hospital division and a mental and behavioral health division, which make up our Healthcare segment, a biospecimens division, which makes up our Life Science Services segment and an epigenetics diagnostics and interpretation division, which makes up our Labs segment. Our rural hospital division, biospecimens division and epigenetics diagnostics and interpretation division operate through wholly owned subsidiaries, and our behavioral health division operates through a majority-owned subsidiary.
In the news
FOXO TECHNOLOGIES, INC., FORMS STRATEGIC PARTNERSHIP WITH LONGEVITYFP TECHNOLOGIES, LLC. TO COMMERCIALIZE FOXO’S EPIGENETICS TECHNOLOGY ↗
Recent filings
DEF 14C filing
PRE 14C filing
10-Q filing
Submission of Matters to a Vote of Security Holders
Items 5.07
Regulation FD Disclosure
Items 7.01, 9.01
Show 5 more recent filings
Entry into a Material Definitive Agreement
Items 1.01, 9.01
Regulation FD Disclosure
Items 7.01, 9.01
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year · Regulation FD Disclosure
Items 5.03, 7.01, 9.01
DEF 14C filing
Entry into a Material Definitive Agreement · Regulation FD Disclosure
Items 1.01, 7.01, 9.01
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 44,577,873Source | 41,708,071Source | 725,000Source | 35,408,000Source |
| Property, Plant and Equipment, NetUSD | 322,357Source | 364,481Source | 13,641Source | — |
| GoodwillUSD | 27,823,444Source | 25,463,948Source | — | — |
| Intangible Assets, Net (Excluding Goodwill)USD | 9,770,969Source | 9,015,556Source | 378,000Source | 2,043,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 207,453Source | 68,268Source | 38,000Source | 5,515,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 2,468,346Source | 2,270,957Source | — | — |
| Inventory, NetUSD | 183,627Source | — | — | 1,313,000Source |
| Assets, CurrentUSD | 3,112,480Source | 2,881,266Source | 233,000Source | 12,304,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | — | — | — | 2,676,000Source |
| Operating Lease, Right-of-Use AssetUSD | 3,548,623Source | 3,982,820Source | — | — |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 33,501,573Source | 36,436,260Source | 14,825,000Source | 28,700,000Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 249,566Source | 2,356Source | 1,000Source | 3,000Source |
| Additional Paid in CapitalUSD | 235,540,145Source | 195,862,460Source | 162,959,000Source | 153,936,000Source |
| Retained Earnings (Accumulated Deficit)USD | -224,644,739Source | -190,541,067Source | -177,060,000Source | -147,231,000Source |
| Stockholders' Equity Attributable to ParentUSD | 11,144,982Source | 5,323,752Source | -14,100,000Source | 6,708,000Source |
| Liabilities and EquityUSD | 44,577,873Source | 41,708,071Source | 725,000Source | 35,408,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 28,658,760Source | 32,727,461Source | 14,336,000Source | 6,913,000Source |
| Operating Lease, Liability, CurrentUSD | 499,351Source | 367,474Source | — | — |
| Accounts Payable, CurrentUSD | 6,966,211Source | 6,677,281Source | 4,556,000Source | 3,466,000Source |
| Operating Lease, Liability, NoncurrentUSD | 3,174,549Source | 3,667,553Source | — | — |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | -68,682Source | -51,941Source | — | — |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 11,902,383Source | 13,521,416Source | 1,696,000Source | 1,045,000Source |
| Deferred Tax Liabilities, NetUSD | 2,931,071Source | 1,587,905Source | 10,000Source | 450,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -12,447,131Source | -12,420,962Source | — | — |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 597,433Source | 1,235,015Source | 1,279,000Source | 1,487,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | -164,209Source | -101,734Source | 381,000Source | 11,035,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 119,051Source | -553,929Source | — | — |
| Increase (Decrease) in InventoriesUSD | 14,140Source | — | — | — |
| Increase (Decrease) in Accounts PayableUSD | 186,251Source | 1,157,448Source | 1,297,000Source | 127,000Source |
| Deferred Income Tax Expense (Benefit)USD | -182,831Source | — | — | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -3,865,117Source | -2,840,614Source | -6,645,000Source | -23,760,000Source |
| Cash flows from investing activities: | ||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | -13,329Source | — | — |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -655,606Source | 13,329Source | — | -1,870,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 62,021Source | — | — | 110,000Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 4,659,908Source | 2,857,437Source | 1,168,000Source | 24,289,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | -1,341,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 207,453Source | 68,268Source | 38,000Source | 5,515,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | 1,219,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | — | 100,000Source | 732,000Source | — |
| Amortization of Debt Issuance CostsUSD | — | — | 616,000Source | 91,000Source |
| Amortization of Debt Issuance Costs and DiscountsUSD | 1,763,189Source | 1,376,498Source | 448,000Source | — |
| Amortization of Intangible AssetsUSD | 31,992Source | 1,000,000Source | 1,257,000Source | — |
| DepreciationUSD | 100,000Source | 100,000Source | — | 1,487,000Source |
| Equity Method Investment, Other than Temporary ImpairmentUSD | — | — | — | 1,307,000Source |
| Fair Value, Option, Changes in Fair Value, Gain (Loss)USD | — | — | — | -28,180,000Source |
| Gain (Loss) on Extinguishment of DebtUSD | 1,863,834Source | -428,295Source | — | — |
| GoodwillUSD | 27,823,444Source | 25,463,948Source | — | — |
| Goodwill and Intangible Asset ImpairmentUSD | — | — | — | 63,000Source |
| Goodwill, Impairment LossUSD | 7,000,000Source | 0Source | — | — |
| Impairment of Intangible Assets (Excluding Goodwill)USD | — | 1,847,994Source | — | — |
| Impairment of Intangible Assets, Finite-livedUSD | — | 1,848,402Source | 2,633,000Source | 1,370,000Source |
| Income Tax Expense (Benefit)USD | -182,831Source | — | — | — |
| Net Income (Loss) Attributable to ParentUSD | -12,430,390Source | -12,406,389Source | -26,451,000Source | -95,255,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | -16,741Source | -14,573Source | — | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -35,041,481Source | -13,561,708Source | -29,829,000Source | -45,437,000Source |
| Nonoperating Income (Expense)USD | -2,300,748Source | -4,659,048Source | -4,263,000Source | — |
| Operating ExpensesUSD | 26,696,831Source | 11,813,515Source | 22,201,000Source | 40,334,000Source |
| Operating Lease, ExpenseUSD | — | 352,562Source | — | — |
| Other Nonoperating Income (Expense)USD | -771,823Source | -287,988Source | 19,000Source | -207,000Source |
| Other Operating Income (Expense), NetUSD | — | — | — | -55,088,000Source |
| Payments for Repurchase of WarrantsUSD | — | — | — | 507,000Source |
| Payments of Financing CostsUSD | — | — | 299,000Source | 540,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | -30,561,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 16,367,617Source | 4,051,601Source | — | — |
| Cost of RevenueUSD | — | — | — | 344,000Source |
| Selling, General and Administrative ExpenseUSD | 11,358,767Source | 7,225,124Source | 19,399,000Source | 27,196,000Source |
| Operating Income (Loss)USD | -10,329,214Source | -7,761,914Source | -22,188,000Source | -40,167,000Source |
| Other Nonoperating Income (Expense)USD | -771,823Source | -287,988Source | 19,000Source | -207,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -12,629,962Source | -12,420,962Source | — | — |
| Income Tax Expense (Benefit)USD | -182,831Source | — | — | — |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | -16,741Source | -14,573Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | -12,430,390Source | -12,406,389Source | -26,451,000Source | -95,255,000Source |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 31,992Source | 1,000,000Source | 1,257,000Source | — |
| Fair Value, Option, Changes in Fair Value, Gain (Loss)USD | — | — | — | -28,180,000Source |
| Goodwill, Impairment LossUSD | 7,000,000Source | 0Source | — | — |
| Gross ProfitUSD | — | — | 13,000Source | 167,000Source |
| Income (Loss) Attributable to Parent, before TaxUSD | — | — | -26,451,000Source | — |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | -95,255,000Source |
| Interest ExpenseUSD | — | — | — | 1,440,000Source |
| Interest Expense, DebtUSD | 3,434,005Source | 3,910,340Source | — | — |
| Management Fee ExpenseUSD | — | — | 595,000Source | 8,695,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -35,041,481Source | -13,561,708Source | -29,829,000Source | -45,437,000Source |
| Nonoperating Income (Expense)USD | -2,300,748Source | -4,659,048Source | -4,263,000Source | — |
| Operating ExpensesUSD | 26,696,831Source | 11,813,515Source | 22,201,000Source | 40,334,000Source |
| Operating Lease, ExpenseUSD | — | 352,562Source | — | — |
| Other ExpensesUSD | — | 300,000Source | — | 5,649,000Source |
| Other Operating Income (Expense), NetUSD | — | — | — | -55,088,000Source |
| Preferred Stock Dividends and Other AdjustmentsUSD | 937,809Source | 81,326Source | — | — |
| Preferred Stock Dividends, Income Statement ImpactUSD | 112,500Source | 1,073,993Source | 3,378,000Source | — |
| Research and Development ExpenseUSD | 182,498Source | 312,267Source | 901,000Source | 3,047,000Source |
Offerings
Registration 333-293288
Registration 333-287818
- Offering price
- market-price
- Ticker
- FOXO
Registration 333-286953
- Offering price
- market-price
- Ticker
- FOXO
Filing attachments
ex99-1.htm · 8-K · 2026-07-29
EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 FOXO TECHNOLOGIES INC.’S SUBSIDIARY VECTOR BIOSOURCE, INC. ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE FOUR BLOOD COLLECTION CENTERS FROM GRIFOLS BIO SUPPLIES, INC. WEST PALM BEACH, FL, July 29, 2026 (GLOBE NEWSWIRE) - FOXO Technologies Inc.’s (OTC: FOXOD/FOXO) ( “FOXO”) subsidiary, Vector BioSource, Inc. (“Vector”) today announced that it has entered into a definitive agreement to acquire four U.S.-based blood collection centers (the “Agreement”) …
Read attachment ↗ex99-1.htm · 8-K · 2026-07-06
EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 FOXO TECHNOLOGIES INC. CEO SEAMUS LAGAN PROVIDES MID-YEAR UPDATE TO SHAREHOLDERS WEST PALM BEACH, FL, July 6, 2026 (GLOBE NEWSWIRE) - FOXO Technologies Inc. (OTC: FOXOD/FOXO) (the “Company”) announces the following mid-year update to shareholders by the Company’s Chief Executive Officer Seamus Lagan. FOXO Shareholders: As we have reached the mid-year point of the year, I wanted to provide our shareholders with an update on achievements for the fi…
Read attachment ↗ex99-1.htm · 8-K · 2026-07-01
EX-99.1 3 ex99-1.htm EX-99.1 Exhibit 99.1 FOXO TECHNOLOGIES INC. ANNOUNCES COMPLETION OF REVERSE STOCK SPLIT WEST PALM BEACH, FLORIDA - July 1, 2026 - (Globenewswire) - FOXO Technologies Inc. (OTC: FOXO) (“FOXO” or the “ Company ”), today announced that its previously approved reverse stock split (the “Reverse Split”) of its Class A common stock (“Common Stock” and the “Reverse Split”) became effective at 4:01 p.m. ET on June 30, 2026 (the “Effective Time”). The Company’s Common Stock will…
Read attachment ↗ex99-1.htm · 8-K · 2026-05-28
EX-99.1 3 ex99-1.htm EX-99.1 Exhibit 99.1 FOXO TECHNOLOGIES, INC., FORMS STRATEGIC PARTNERSHIP WITH LONGEVITYFP TECHNOLOGIES, LLC. TO COMMERCIALIZE FOXO’S EPIGENETICS TECHNOLOGY WEST PALM BEACH, FL and MINNETONKA, MN, May 28, 2026 (GLOBE NEWSWIRE) - FOXO Technologies Inc. (OTC: FOXO) (the “Company”) and LongevityFP Technologies, LLC. (“LFP”) today jointly announced a strategic partnership to commercialize the Company’s pioneering epigenetics technology. The partnership is in the form of an…
Read attachment ↗ex4-1.htm · 8-K · 2026-05-18
EX-4.1 2 ex4-1.htm EX-4.1 Exhibit 4.1 PROMISSORY NOTE $5,307,096.94 May 12, 2026 FOR VALUE RECEIVED, Foxo Technologies Inc., a Delaware corporation (the “ Maker ”) promises to pay to the order of Sabby Volatility Warrant Master Fund, Ltd., or its registered assigns (the “ Payee ”), upon the terms set forth below, the principal sum of Five Million Three Hundred and Seven Thousand, and Ninety Six Dollars and Ninety Four Cents ($5,307,096.94). (This Promissory Note, the “ Note ”). 1.…
Read attachment ↗ex4-2.htm · 8-K · 2026-05-18
EX-4.2 3 ex4-2.htm EX-4.2 Exhibit 4.2 PROMISSORY NOTE $2,467,988.34 May 12, 2026 FOR VALUE RECEIVED, Foxo Technologies Inc., a Delaware corporation (the “ Maker ”) promises to pay to the order of Sabby Healthcare Master Fund, Ltd., or its registered assigns (the “ Payee ”), upon the terms set forth below, the principal sum of Two Million Four Hundred and Sixty Seven Thousand, Nine Hundred and Eighty Eight Dollars and Thirty Four Cents $2,467,988.34). (This Promissory Note, the “ No…
Read attachment ↗